The novel variant rs2259926 is associated with gene expression regulation, affecting ABHD12 (α/β hydrolase domain-containing protein 12), essential for lipid metabolism crucial for brain function, making it a potential therapeutic target for ALS. The gene discussed is ABHD12; the disease is amyotrophic lateral sclerosis.